Making clinical trials more diverse isn’t just the right thing to do — it’s essential for developing treatments that work for everyone. Yet, despite FDA guidance, many trials still fail to reflect the real-world diversity of…
For decades, clinical trials have struggled with a deep-rooted problem: a lack of diversity. Racial and ethnic minorities, individuals in non-English-speaking communities, and patients outside of research-heavy geographies remain consistently underrepresented in studies. This isn’t just…
This year’s SCOPE was amazing and well attended with over 3100 people coming from around the globe representing sponsors, CROs, suppliers, consultants and most importantly patients. Coming off last year where there was a fraction of…
Underrepresentation of minorities in clinical research leads to issues such as health disparities, lack of trust in the medical system, limited access to new treatments and inaccurate treatment recommendations for those populations. So, it is important…
With 7.5+ billion people across the globe, humans come in various hues. And while we have a lot in common, we are unique in genetics, food habits, race, ethnicity, culture and language among many others. In…
A clinical trial is a research study conducted on human volunteers to analyze the safety and efficacy of novel therapies or devices so that they can be used by everyone. Therefore, it is important that the…
Diversity in clinical trials is crucial to understanding the effectiveness of drugs in different ethnic populations. The inclusion of participants from different races and ethnicity also ensures the generalization of the result and helps achieve health…
